title: Can the profile of preformed HLA antibodies in highly sensitized recipients influence the outcome of their kidney transplants?
authors.affiliation: INSERM U93, Hôpital Saint Louis, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Busson
authors.forename: A M
authors.initials: AM
authors.lastname: Bouteiller
authors.forename: P
authors.initials: P
authors.lastname: Prevost
authors.forename: C
authors.initials: C
authors.lastname: Raffoux
authors.forename: H
authors.initials: H
authors.lastname: Betuel
authors.forename: R
authors.initials: R
authors.lastname: Fauchet
authors.forename: J D
authors.initials: JD
authors.lastname: Bignon
authors.forename: F
authors.initials: F
authors.lastname: Guigner
authors.forename: M
authors.initials: M
authors.lastname: Calot
authors.forename: P
authors.initials: P
authors.lastname: Mercier
mesh_terms: D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007109:Immunity; D007518:Isoantibodies / Q000276:immunology*; D016030:Kidney Transplantation; D007700:Kinetics; D011379:Prognosis
chemical_list: D006680:HLA Antigens; D007518:Isoantibodies